Reactivation of latent HIV-1 provirus via targeting protein phosphatase-1

Mudit Tyagi1, Sergey Iordanskiy2, Tatyana Ammosova3,4,5

  • 1Department of Medicine, The George Washington University, Washington, DC, 2003, USA. tmudit@email.gwu.edu.

Retrovirology
|July 17, 2015
PubMed
Abstract

Insights

Researchers developed novel small molecules that reactivate latent HIV-1 by targeting protein phosphatase-1 (PP1), enhancing viral transcription and offering a potential cure for HIV.

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • Human immunodeficiency virus type 1 (HIV-1) establishes latent reservoirs by integrating into host DNA, hindering eradication efforts.
  • Reactivation of latent HIV-1 requires transcriptional activation, often impaired in infected cells due to low levels of transcription factors like P-TEFb (CDK9/cyclin T1).
  • Protein phosphatase-1 (PP1) has been shown to regulate HIV-1 transcription by modulating CDK9 phosphorylation, and novel compounds targeting PP1 have been developed.

Purpose of the Study:

  • To develop and evaluate a new class of small molecular compounds targeting a non-catalytic site of PP1 for HIV-1 reactivation.
  • To investigate the mechanism by which these compounds reactivate latent HIV-1, focusing on PP1 activity and CDK9 phosphorylation.

Main Methods:

  • Synthesis and testing of novel sulfonamide-containing compounds, including a specific small molecule activator of PP1 (SMAPP1).
  • Assessing HIV-1 replication and latent reservoir reactivation in acutely and chronically infected cells (cultured and primary).
  • In vitro assays to confirm SMAPP1 interaction with PP1 and its effect on PP1 activity, CDK9 phosphorylation, and protein expression via proteomic analysis. Docking analysis was used to identify the binding site.

Main Results:

  • A novel class of sulfonamide compounds, including SMAPP1, demonstrated activation of HIV-1 in both acute and latent infections.
  • SMAPP1 effectively reactivated latent HIV-1 in chronically infected cells and increased HIV-1 replication.
  • SMAPP1 enhanced PP1 activity, increased phosphorylation of CDK9 at specific residues (Ser90 and Thr186), and led to the upregulation of PP1 and P-TEFb related proteins.

Conclusions:

  • A novel class of PP1-targeting compounds, exemplified by SMAPP1, can reactivate latent HIV-1 provirus.
  • These compounds work by enhancing PP1 activity, increasing CDK9 phosphorylation, and boosting HIV transcription.
  • This discovery presents a promising new therapeutic strategy for eradicating latent HIV-1 reservoirs.

Related Concept Videos

Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
1.1K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
14.0K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.6K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.7K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.2K